In this scenario marine microalgae are emerging as rich sources of a wide range of bioactive metabolites with anti-antioxidant and anti-inflammatory properties that can serve as potential new therapeutic agents to treat or prevent the severe symptoms of COVID-19, possibly by enhancing IL-10 levels (298, 299). The gene discussed is IL10; the disease is COVID-19.